Comparison of physicians' and cancer prone women's attitudes about breast/ovarian prophylactic surgery. Results from two national surveys
Explore this paper's citation graph
Summary
The results indicate that assumed reduced mortality is not the main criterion for prophylactic oophorectomy acceptability, and it was anticipated that prophyllactic mastectomy should be rarely performed in France.
- Type
- article
- Published
- 2004-01-01
- Cited by
- 12
- References
- 31
- OpenAlex
- https://openalex.org/W303097775
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:23007184
Keywords
Medicine, Breast cancer, Ovarian cancer, Epidemiology, Prophylactic Surgery
References
- Population-based study of risk of breast cancer in carriers of BRCA2 mutation.
- Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
- Prophylactic oophorectomy in inherited breast/ovarian cancer families.
- Decision-making about breast cancer susceptibility testing: how similar are the attitudes of physicians, nurse practitioners, and at-risk women?
- Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients.
- Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations.
- Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.
- Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
- Acceptability of prophylactic mastectomy in cancer-prone women.
- Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact.
- Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
- THE INCIDENCE OF OBSCURE CARCINOMA IN SUBCUTANEOUS MASTECTOMY: Results of a National Survey
- Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women. Italian Tamoxifen Prevention Study.
- Genetic testing for susceptibility to adult-onset cancer. The process and content of informed consent.
- Primary breast cancer after prophylactic mastectomy.
- Physicians' attitudes towards mammography and prophylactic surgery for hereditary breast/ovarian cancer risk and subsequently published guidelines
- Cultural basis for differences between US and French clinical recommendations for women at increased risk of breast and ovarian cancer.
- Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.
- Mammography in Asian patients with BRCA1 mutations.
- Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
Cited by
- Étude des facteurs modificateurs du risque de cancer du sein des femmes à risque génétique élevé
- Prophylactic mastectomy for the prevention of breast cancer.
- Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers
- Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers
- Risk-reducing surgery in women with familial susceptibility for breast and/or ovarian cancer.
- Localizing the Global
- Anticipating family issues associated with cancer risk assessment and genetic testing
- PPAC (programme personnalisé de l’après-cancer) : rationnel et mise en place
- Risk-reducing mastectomy for the prevention of primary breast cancer.
- Time trends in uptake rates of risk-reducing mastectomy in Israeli asymptomatic BRCA1 and BRCA2 mutation carriers
- Defining and measuring acceptability of surgical interventions: A scoping review
Related papers
- Epidemiology of clinical allergy
- EPIWEEK: Stata module to create epidemiological week and equivalent epidemiological year
- Teaching Epidemiology: What You Should Know and What You Could Do
- Профілактична бімастектомія як спосіб профілактики контралатерального раку молочної залози
- High Risk for Ovarian Cancer in a Prospective Series Is Restricted to BRCA1/2 Mutation Carriers
- Genetic susceptibility testing and prophylactic oophorectomy.
- Managing hereditary ovarian cancer risk
- Familial ovarian cancer.
- Breast Reduction Surgery and Breast Cancer Risk: Does Reduction Mammaplasty Have a Role in Primary Prevention Strategies for Women at High Risk of Breast Cancer?